Authors: LISSONI P MENGO S MANDALA M MAURI E BRIVIO F ROVELLI F CONFALONIERI G LONGARINI R BONFANTE A FOLLI D MEREGALLI S BARNI S TANCINI G GIANI L

Citation: P. Lissoni et al., PHYSIOPATHOLOGY OF IL-12 IN HUMAN SOLID NEOPLASMS - BLOOD-LEVELS OF IL-12 IN EARLY OR ADVANCED CANCER-PATIENTS, AND THEIR VARIATIONS WITH SURGERY AND IMMUNOTHERAPY, Journal of biological regulators and homeostatic agents, 12(1-2), 1998, pp. 38-41

Authors: LISSONI P MANDALA M ROVELLI F GIANI L BARNI S MAURI E TANCINI G FUMAGALLI L DIFELICE G MAIORCA F MEREGALLI S

Citation: P. Lissoni et al., EFFECT OF INTERLEUKIN-12 IMMUNOTHERAPY ON ENDOGENOUS SECRETION OF INTERLEUKIN-2 IN METASTATIC CANCER-PATIENTS, International journal of immunotherapy, 14(2), 1998, pp. 101-104

Authors: LISSONI P FUMAGALLI L DIFELICE G MENGO S MAURI E MERLINI D MEREGALLI S ROVELLI F BARNI S TANCINI G

Citation: P. Lissoni et al., PROGNOSTIC-SIGNIFICANCE OF CHANGES IN IL-12 SECRETION DURING CANCER-IMMUNOTHERAPY WITH IL-2 - PRELIMINARY CONSIDERATIONS, International journal of immunotherapy, 13(1-2), 1997, pp. 17-23

Authors: SANCHEZ C MAURI E DALMAU D

Citation: C. Sanchez et al., HIGH-DOSE ITRACONAZOLE FOR THE TREATMENT OF CEREBRAL ASPERGILLOSIS - REPLY, Clinical infectious diseases, 23(5), 1996, pp. 1197-1197

Authors: BALSELLS M MAURI E GARCIAPASCUAL L DELPOZO C ANGLADA J

Citation: M. Balsells et al., ECTOPIC CUSHING-SYNDROME WITH CYCLIC ACTI VITY - DIAGNOSTIC DIFFICULTIES, Revista Clinica Espanola, 196(12), 1996, pp. 881-883

Authors: SANCHEZ C MAURI E DALMAU D QUINTANA S APARICIO A GARAU J

Citation: C. Sanchez et al., TREATMENT OF CEREBRAL ASPERGILLOSIS WITH ITRACONAZOLE - DO HIGH-DOSESIMPROVE THE PROGNOSIS, Clinical infectious diseases, 21(6), 1995, pp. 1485-1487